Long-Lasting Response after Pembrolizumab in a Patient with Metastatic Triple-Negative Breast Cancer

INTRODUCTION: Breast cancer is the first cause of cancer death in women. The triple-negative subtype is associated with aggressive behavior and poor prognosis. Chemotherapy is the main therapeutic option available for these patients, but it is usually associated with short overall survival. CASE PRE...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Care (Basel)
Hlavní autoři: Peinado, Paloma, Ramírez, Carmen, García-Sáenz, José Angel, Pascual, Alejandro, Fuentes-Antrás, Jesús, Vidal, Natalia, Antoñanzas, Mónica, Moreno, Fernando
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger GmbH 2020
Témata:
Novel Insights from Clinical Practice
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490656/
https://ncbi.nlm.nih.gov/pubmed/32982655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503849
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky